Search research articles
Contact Us
Filters
Showing results (261-270 of 418) with videos related to
Page
of 42
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 5, 2012
Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data
Antonio Rossi, Massimo Di Maio, Paolo Chiodini, et al.
The Lancet Regional Health. Europe
|
March 13, 2024
Challenges and controversies in resectable non-small cell lung cancer: a clinician's perspective
Ilias Houda, Chris Dickhoff, Carin A Uyl-de Groot, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 12, 2018
Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma
Joanna Kopecka, Iris C Salaroglio, Luisella Righi, et al.
Cancers
|
August 14, 2020
Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience
Valentina Tuninetti, Marilena Di Napoli, Eleonora Ghisoni, et al.
Clinical Lung Cancer
|
January 15, 2014
Rationale and design of MILES-3 and MILES-4 studies: two randomized phase 3 trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non--small-cell lung cancer
Cesare Gridelli, Antonio Rossi, Massimo Di Maio, et al.
Tumori
|
October 18, 2025
Inter-hospital heterogeneity in the authorizations of off-label cancer drugs: A project by Associazione Italiana di Oncologia Medica
Anna Amela Valsecchi, Matilde Scaldaferri, Marcello Tiseo, et al.
Journal of Translational Medicine
|
July 31, 2024
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung)
Fabrizio Citarella, Kazuki Takada, Priscilla Cascetta, et al.
Clinical Lung Cancer
|
November 21, 2017
Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer
Elisa Gobbini, Sara Pilotto, Giulia Pasello, et al.
Breast (Edinburgh, Scotland)
|
June 17, 2020
Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II trial of the Gruppo Oncologico Italia Meridionale (GOIM)
Laura Orlando, Vito Lorusso, Francesco Giotta, et al.
Orphanet Journal of Rare Diseases
|
August 14, 2025
6-year treatment follow-up with an extended-release alkaline formulation (Sibnayal<sup>®</sup>) in primary distal renal tubular acidosis
Aurélia Bertholet-Thomas, Aurélie De Mul, Julie Bernardor, et al.
Page
of 42
Search research articles
Search
Showing results (261-270 of 418) with videos related to
Sort By:
Page
of 42
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 5, 2012
Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data
Antonio Rossi, Massimo Di Maio, Paolo Chiodini, et al.
The Lancet Regional Health. Europe
|
March 13, 2024
Challenges and controversies in resectable non-small cell lung cancer: a clinician's perspective
Ilias Houda, Chris Dickhoff, Carin A Uyl-de Groot, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 12, 2018
Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma
Joanna Kopecka, Iris C Salaroglio, Luisella Righi, et al.
Cancers
|
August 14, 2020
Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience
Valentina Tuninetti, Marilena Di Napoli, Eleonora Ghisoni, et al.
Clinical Lung Cancer
|
January 15, 2014
Rationale and design of MILES-3 and MILES-4 studies: two randomized phase 3 trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non--small-cell lung cancer
Cesare Gridelli, Antonio Rossi, Massimo Di Maio, et al.
Tumori
|
October 18, 2025
Inter-hospital heterogeneity in the authorizations of off-label cancer drugs: A project by Associazione Italiana di Oncologia Medica
Anna Amela Valsecchi, Matilde Scaldaferri, Marcello Tiseo, et al.
Journal of Translational Medicine
|
July 31, 2024
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung)
Fabrizio Citarella, Kazuki Takada, Priscilla Cascetta, et al.
Clinical Lung Cancer
|
November 21, 2017
Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer
Elisa Gobbini, Sara Pilotto, Giulia Pasello, et al.
Breast (Edinburgh, Scotland)
|
June 17, 2020
Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II trial of the Gruppo Oncologico Italia Meridionale (GOIM)
Laura Orlando, Vito Lorusso, Francesco Giotta, et al.
Orphanet Journal of Rare Diseases
|
August 14, 2025
6-year treatment follow-up with an extended-release alkaline formulation (Sibnayal<sup>®</sup>) in primary distal renal tubular acidosis
Aurélia Bertholet-Thomas, Aurélie De Mul, Julie Bernardor, et al.
Page
of 42